MedPath

Binacea Pharma, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
https://binaceapharma.com/

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Refractory Solid Tumors
Interventions
First Posted Date
2021-12-09
Last Posted Date
2022-09-27
Lead Sponsor
Binacea Pharma, Inc.
Target Recruit Count
48
Registration Number
NCT05150457
Locations
🇦🇺

St George Private Hospital, Kogarah, New South Wales, Australia

🇦🇺

St. Vincents Hospital Melbourne, Fitzroy, Victoria, Australia

🇦🇺

Pindara Private Hospital, Benowa, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath